{
      "Rank": 1,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Placebo",
            "Low dose (total of 600 million cells)",
            "High dose (total of 1200 cells)"
      ],
      "ArmGroupInterventionName": [
            "Drug: Placebo",
            "Drug: PROCHYMAL adult human mesenchymal stem cells",
            "Drug: PROCHYMAL adult human mesenchymal stem cells"
      ],
      "ArmGroupLabel": [
            "Placebo",
            "PROCHYMAL Low dose",
            "PROCHYMAL High dose"
      ],
      "ArmGroupType": [
            "Placebo Comparator",
            "Active Comparator",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT00543374"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Protocol 610 is enrolling subjects who successfully achieved clinical benefit (reduction in Crohn's Disease Activity Index (CDAI) of at least 100 points) in Protocol 603. Protocol 610 is evaluating the length of initial effect of PROCHYMAL\u00ae adult human mesenchymal stem cells and the ability of these cells to successfully re-induce clinical benefit."
      ],
      "BriefTitle": [
            "Extended Evaluation of PROCHYMAL\u00ae Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "April 28, 2011"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Crohn's Disease"
      ],
      "ConditionAncestorId": [
            "D000015212",
            "D000005759",
            "D000005767",
            "D000004066",
            "D000007410"
      ],
      "ConditionAncestorTerm": [
            "Inflammatory Bowel Diseases",
            "Gastroenteritis",
            "Gastrointestinal Diseases",
            "Digestive System Diseases",
            "Intestinal Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC06",
            "All"
      ],
      "ConditionBrowseBranchName": [
            "Digestive System Diseases",
            "All Conditions"
      ],
      "ConditionBrowseLeafAsFound": [
            "Crohn's Disease"
      ],
      "ConditionBrowseLeafId": [
            "M5790",
            "M9596",
            "M17069",
            "M8027",
            "M8035",
            "M6407"
      ],
      "ConditionBrowseLeafName": [
            "Crohn Disease",
            "Intestinal Diseases",
            "Inflammatory Bowel Diseases",
            "Gastroenteritis",
            "Gastrointestinal Diseases",
            "Digestive System Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000003424"
      ],
      "ConditionMeshTerm": [
            "Crohn Disease"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Quadruple"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant",
            "Care Provider",
            "Investigator",
            "Outcomes Assessor"
      ],
      "DetailedDescription": [
            "A significant number of individuals with Crohn's disease do not find relief with existing steroidal, immunosuppressive, or biologic therapies, and are forced to seek surgery or other drastic measures for treatment.\n\nPROCHYMAL\u00ae adult human stem cells are manufactured from healthy, volunteer donors, extensively tested, and are stored to be available as needed. Human and animal studies have shown that the cells do not require any donor-recipient matching. The cells may have both immunosuppressive and healing benefits in Crohn's disease. The cells naturally migrate specifically to sites of inflammation, so their effects are believed to be local and self-limiting rather than systemic.\n\nProtocol 610 is an extension study offered only to those subjects who successfully achieved clinical benefit (reduction of CDAI of at least 100 points) in Protocol 603."
      ],
      "DispFirstPostDate": [
            "October 10, 2011"
      ],
      "DispFirstPostDateType": [
            "Estimate"
      ],
      "DispFirstSubmitDate": [
            "August 24, 2010"
      ],
      "DispFirstSubmitQCDate": [
            "October 6, 2011"
      ],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nParticipation in Osiris Protocol 603, with drop of at least 100 points in CDAI at Day 28\n\nExclusion Criteria:\n\nSubstance abuse\nFailure to receive full dose of all interventions in Protocol 603"
      ],
      "EnrollmentCount": [
            "98"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [
            "D000000893",
            "D000000998",
            "D000000890"
      ],
      "InterventionAncestorTerm": [
            "Anti-Inflammatory Agents",
            "Antiviral Agents",
            "Anti-Infective Agents"
      ],
      "InterventionArmGroupLabel": [
            "Placebo",
            "PROCHYMAL High dose",
            "PROCHYMAL Low dose"
      ],
      "InterventionBrowseBranchAbbrev": [
            "Infe",
            "Infl",
            "All"
      ],
      "InterventionBrowseBranchName": [
            "Anti-Infective Agents",
            "Anti-Inflammatory Agents",
            "All Drugs and Chemicals"
      ],
      "InterventionBrowseLeafAsFound": [
            "Unsuccessful"
      ],
      "InterventionBrowseLeafId": [
            "M186752",
            "M3369",
            "M3466",
            "M3366"
      ],
      "InterventionBrowseLeafName": [
            "Remestemcel-l",
            "Anti-Inflammatory Agents",
            "Antiviral Agents",
            "Anti-Infective Agents"
      ],
      "InterventionBrowseLeafRelevance": [
            "high",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [
            "Placebo",
            "intravenous infusion four times over two weeks; possibly repeated once"
      ],
      "InterventionMeshId": [
            "C000711674"
      ],
      "InterventionMeshTerm": [
            "Remestemcel-l"
      ],
      "InterventionName": [
            "Placebo",
            "PROCHYMAL adult human mesenchymal stem cells"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Drug",
            "Drug"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "Yes"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "December 28, 2021"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "December 23, 2021"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Mesoblast, Inc."
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Anaheim",
            "Long Beach",
            "Los Angeles",
            "San Francisco",
            "Wheat Ridge",
            "Hamden",
            "Clearwater",
            "Jacksonville",
            "Miami",
            "Winter Park",
            "Atlanta",
            "Chicago",
            "Urbana",
            "Indianapolis",
            "Topeka",
            "Lexington",
            "Louisville",
            "Baton Rouge",
            "Bethesda",
            "Chevy Chase",
            "Boston",
            "Boston",
            "Worcester",
            "Dearborn",
            "Troy",
            "Minneapolis",
            "Saint Louis",
            "Lebanon",
            "Cedar Knolls",
            "Teaneck",
            "New York",
            "New York",
            "Rochester",
            "Rochester",
            "Stony Brook",
            "Charlotte",
            "Pinehurst",
            "Winston-Salem",
            "Dayton",
            "Tulsa",
            "Tulsa",
            "Pittsburgh",
            "Pittsburgh",
            "Germantown",
            "Nashville",
            "Nashville",
            "Dallas",
            "Galveston",
            "Houston",
            "Burlington",
            "Norfolk",
            "Richmond",
            "Seattle",
            "Calgary",
            "Edmonton",
            "Winnipeg",
            "London",
            "Toronto"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada"
      ],
      "LocationFacility": [
            "Advanced Clinical Research Institute",
            "Veteran's Administration Medical Center (does not require vet status)",
            "University of Southern California University Hospital",
            "University of California, San Francisco",
            "Western States Clinical Research",
            "Gastroenterology Center of Connecticut",
            "Clinical Research of West Florida",
            "Borland-Groover Clinic",
            "Venture Research Institute",
            "Shafran Gastroenterology Center",
            "Atlanta Gastroenterology Associates",
            "University of Chicago Medical Center",
            "Carle Clinic Association",
            "Indiana University Medical Center",
            "Cotton-O'Neil Clinical Research Center",
            "University of Kentucky Hospital",
            "University of Louisville Hospital",
            "Gulf Coast Research",
            "National Institutes of Health",
            "Metropolitan Gastroenterology Group",
            "Massachusetts General Hospital",
            "Brigham and Womens Hospital",
            "Clinical Pharmacology Study Group",
            "Center for Clinical Studies",
            "Center for Digestive Health",
            "University of Minnesota Hospital",
            "St Louis Center for Clinical Studies",
            "Dartmouth Hitchcock Medical Center",
            "Gastroenterology Research Associates",
            "Holy Name Hospital",
            "Weill Cornell Medical College",
            "Mount Sinai School of Medicine",
            "Rochester Institute for Digestive Diseases",
            "Rochester General Hospital",
            "University Hospital and Medical Center",
            "Charlotte Gastroenterology and Hepatology",
            "Pinehurst Medical Clinic",
            "Wake Forest University",
            "Dayton Science Institute",
            "Gastroenterology United of Tulsa",
            "Options Health Research",
            "Allegheney Center for Digestive Health",
            "University of Pittsburgh",
            "Gastroenterology Center of the Midsouth",
            "Nashville GI Specialists",
            "Vanderbilt University Medical Center",
            "Baylor University Medical Center",
            "University of Texas Medical Branch",
            "Memorial Hermann Hospital",
            "University of Vermont",
            "Digestive and Liver Disease Specialists",
            "McGuire Research Institute",
            "Seattle Gastroenterology Associates",
            "University of Calgary",
            "University of Alberta Hospital",
            "Health Sciences Centre",
            "London Health Sciences Centre",
            "Mount Sinai Hospital"
      ],
      "LocationState": [
            "California",
            "California",
            "California",
            "California",
            "Colorado",
            "Connecticut",
            "Florida",
            "Florida",
            "Florida",
            "Florida",
            "Georgia",
            "Illinois",
            "Illinois",
            "Indiana",
            "Kansas",
            "Kentucky",
            "Kentucky",
            "Louisiana",
            "Maryland",
            "Maryland",
            "Massachusetts",
            "Massachusetts",
            "Massachusetts",
            "Michigan",
            "Michigan",
            "Minnesota",
            "Missouri",
            "New Hampshire",
            "New Jersey",
            "New Jersey",
            "New York",
            "New York",
            "New York",
            "New York",
            "New York",
            "North Carolina",
            "North Carolina",
            "North Carolina",
            "Ohio",
            "Oklahoma",
            "Oklahoma",
            "Pennsylvania",
            "Pennsylvania",
            "Tennessee",
            "Tennessee",
            "Tennessee",
            "Texas",
            "Texas",
            "Texas",
            "Vermont",
            "Virginia",
            "Virginia",
            "Washington",
            "Alberta",
            "Alberta",
            "Manitoba",
            "Ontario",
            "Ontario"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "92801",
            "90822",
            "90033",
            "94115",
            "80033",
            "06518",
            "33765",
            "32256",
            "33162",
            "32789",
            "30342",
            "60637",
            "61801",
            "46202",
            "66606",
            "40536",
            "40202",
            "70808",
            "20892",
            "20815",
            "02114",
            "02115",
            "01610",
            "48124",
            "48098",
            "55455",
            "63128",
            "03756",
            "07927",
            "07666",
            "10028",
            "10029",
            "14607",
            "14621",
            "11794",
            "28207",
            "28734",
            "27157",
            "45415",
            "74135",
            "74137",
            "15212",
            "15213",
            "37138",
            "37205",
            "37232",
            "75246",
            "77555",
            "77030",
            "05401",
            "23502",
            "23249",
            "98133",
            "T2N 4N1",
            "T6G 2X8",
            "R3A 1R9",
            "N6A 5A5",
            "M5G 1X5"
      ],
      "MaximumAge": [
            "70 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Durability and Retreatment Study to Evaluate the Safety and Efficacy of PROCHYMAL\u00ae (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Maintenance and Re-induction of Clinical Benefit and Remission in Subjects Experiencing Treatment-refractory Moderate-to-severe Crohn's Disease"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Mesoblast, Ltd."
      ],
      "OrgStudyId": [
            "CRD 610"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Mesoblast, Inc."
      ],
      "OverallOfficialName": [
            "Mahboob Rahman, MD"
      ],
      "OverallOfficialRole": [
            "Study Director"
      ],
      "OverallStatus": [
            "Completed"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 3"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 2009"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "Duration of clinical benefit (Crohn's disease activity index)",
            "Re-induction of clinical benefit (Crohn's disease activity index)"
      ],
      "PrimaryOutcomeTimeFrame": [
            "6 months",
            "6 months"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [
            "Improvement in quality of life (Inflammatory Bowel Disease Questionnaire [IBDQ] instrument)"
      ],
      "SecondaryOutcomeTimeFrame": [
            "6 months"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "September 17, 2007"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "December 2021"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "October 15, 2007"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "October 11, 2007"
      ],
      "StudyFirstSubmitQCDate": [
            "October 12, 2007"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 07, 2022"
      ],
      "WhyStopped": []
}